Alembic Pharma surges on receiving USFDA approval for Candesartan Cilexetil Tablets

21 Jun 2017 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 530.05, up by 7.05 points or 1.35% from its previous closing of Rs. 523.00 on the BSE.

The scrip opened at Rs. 545.00 and has touched a high and low of Rs. 545.00 and Rs. 522.00 respectively. So far 3468 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 709.30 on 23-Mar-2017 and a 52 week low of Rs. 517.00 on 15-Jun-2017.

Last one week high and low of the scrip stood at Rs. 549.55 and Rs. 517.00 respectively. The current market cap of the company is Rs. 9992.29 crore.

The promoters holding in the company stood at 72.68%, while institutions and non-institutions held 13.74% and 13.58% respectively.

Alembic Pharmaceuticals has received US Food & Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA) for Candesartan Cilexetil Tablets, 32 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Atacand Tablets, 32 mg of AstraZeneca Pharmaceuticals LP. Candesartan Cilexetil Tablets are indicated for treatment of hypertension in adults and children and treatment of heart failure (NYHA class II-IV).

According to IMS, Candesartan Cilexetil Tablets, 32mg have an estimated market size of $27 million for twelve months ending December 2016. Alembic now has a total of 57 ANDA approvals (51 final approvals and 6 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×